Clinical Trial Signals · weekly

Newly posted recruiting studies with US sites, every week.

Studies first posted on ClinicalTrials.gov in the past week and listed as recruiting, grouped by state and lead sponsor, with the site, phase, conditions and a link to each official record.

Free one-week sample by reply. Email hello@enrollfeed.com with the states and therapy areas you cover.

Newly posted recruiting studies, Nov 13–20EnrollFeed · Weekly, Monday
Sample
  • Minnesota
  • Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesPhase 2Aclaris Therapeutics, Inc. · New Brighton
  • Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryPhase 2HealthPartners Institute · Saint Paul
  • Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 TrialPhase 3Mayo Clinic · Albert Lea
  • Florida
  • Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution After PTCyPhase 1H. Lee Moffitt Cancer Center and Research Institute · Tampa
ClinicalTrials.gov public records; no contact details

What's newly recruiting, sorted the way you staff it.

  1. Only what's new

    Studies first posted in the past week, listed as recruiting, with at least one US site listed as recruiting.

  2. By state, then sponsor

    Each recruiting site sits under its state and lead sponsor, with facility, city, phase and conditions.

  3. From the public record

    Source: ClinicalTrials.gov. Every row links to the official record and every list shows the registry's data date. No contact names, phone numbers or emails.

This week's list, shortened

Nov 13–20: 39 newly posted studies listed as recruiting, 51 US recruiting sites across 24 states, 38 lead sponsors. Below are real rows from that build.

Newly posted recruiting studies, Nov 13–20 Sample · real rows
Window
First posted Nov 13–20, 2026
Delivery
Weekly by email, Monday by default
Source
ClinicalTrials.gov public records; no contact details
Newly posted recruiting studies with US sites, Nov 13–20, 2026 (sample of real rows)
StudyPhaseConditionsRecruiting siteFirst postedSite status
Minnesota6 sites
Aclaris Therapeutics, Inc.
Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesNCT07935590Phase 2Lichen PlanusAclaris Clinical SiteNew BrightonNov 13Recruiting
HealthPartners Institute
Repurposing Insulin With Intranasal Administration to Improve Function After Mild Traumatic Brain InjuryNCT07935278Phase 2Concussion (Diagnosis), Mild Traumatic Brain InjuryHealthPartners Neuroscience CenterSaint PaulNov 13Recruiting
Mayo Clinic
Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 TrialNCT07935889Phase 3Glioblastoma, IDH-WildtypeMayo Clinic Health System in Albert LeaAlbert LeaNov 13Recruiting
Mayo Clinic Health Systems-MankatoMankatoNov 13Recruiting
Mayo Clinic Radiation Therapy - NorthfieldNorthfieldNov 13Recruiting
Mayo Clinic in RochesterRochesterNov 13Recruiting
Florida5 sites
H. Lee Moffitt Cancer Center and Research Institute
Ph 1 Study Long-acting Interleukin-7, Efineptakin Alfa, to Enhance Immune Reconstitution After PTCyNCT07940738Phase 1Hematologic MalignancyMoffitt Cancer CenterTampaNov 17Recruiting
RAI Services Company
Vuse Pro Puffing Topography Study in Adult SmokersNCT07938320Not applicableSmoking, TobaccoWACDoralNov 16Recruiting
L&E Research TampaTampaNov 16Recruiting
Trevi Therapeutics
A Study of the Potential Pharmacokinetic Interaction Between Quinidine Sulfate and Nalbuphine Extended-Release Tablets (NAL ER) in Healthy ParticipantsNCT07946575Phase 1Healthy ParticipantsClinical Pharmacology of Miami, LLCMiamiNov 18Recruiting
University of Florida
RNA Lipid Particles Targeting Pediatric Recurrent Intracranial Malignancies and Other systEmic Solid Tumors - High Grade GliomaNCT07949071Phase 1, Phase 2Recurrent High-grade GliomaUF HealthGainesvilleNov 19Recruiting
Texas5 sites
Carnegie Mellon University
AI-Driven Hip Exoskeleton Control for Diverse Users and Walking TasksNCT07940127Not applicableHealthy Volunteers, Gait …University of Texas at AustinAustinNov 16Recruiting
+ 4 more sites in this state in the full list

Showing 12 of 51 US recruiting sites. Listed as recruiting as of Nov 20, 2026; may have changed since, check the official record (the NCT link on each row). We don't yet show status changes or newly added sites; those need weekly snapshots to compare.

Data from ClinicalTrials.gov, a U.S. government database. Registry data timestamp: Nov 20, 2026, 10:00:05 (as published; the field has no time zone). Processed: Nov 20, 2026, 3:02 PM ET. Our changes: we keep only studies first posted in the window that are listed as recruiting with at least one US site listed as recruiting, keep only those US sites, group them by state and lead sponsor, shorten condition lists, drop contact details and withhold the names of individual sponsor-investigators. EnrollFeed is not affiliated with or endorsed by ClinicalTrials.gov, NLM or NIH. Sponsors and investigators are responsible for each record. Not medical or enrollment advice. How the list is built.

Simple monthly pricing

No free tier. We charge for selection, formatting and delivery, not for the ClinicalTrials.gov records. Monthly plan that renews automatically. Cancel anytime from the Stripe link in your receipt; cancellation takes effect at the end of the paid period. Refund of your first charge on request within 7 days. US buyers only.

Individual

$149/mo

One recipient.

  • The weekly list by email, Monday by default
  • Grouped by state and lead sponsor, with a link to each NCT record
  • Data timestamp and processing date on every issue
Subscribe for $149/mo

Charges appear on your card statement as OTE Jobs.

Team

$299/mo

Up to 3 people at one organization.

  • Everything in Individual
  • Up to 3 recipients
Subscribe, Team

Charges appear on your card statement as OTE Jobs.

Free one-week sample by reply. Email hello@enrollfeed.com with the states and therapy areas you cover.

Questions

What is in the list?

Studies first posted on ClinicalTrials.gov in the past week that are listed as recruiting and have at least one US site listed as recruiting, with facility, city, state, phase, conditions, lead sponsor and a link to the study record.

Does “newly posted” mean the study just started recruiting or added a site?

No. It means the study record was first posted in the past week and is listed as recruiting. Status changes and new sites will be listed only after we can compare weekly snapshots.

Is the recruiting status current?

It is the status listed on ClinicalTrials.gov as of the data date printed on each list. It may have changed since, so check the official record (the NCT link on each row) before you act on it.

How do I find newly recruiting clinical trials?

ClinicalTrials.gov is the official US registry, and you can search it by recruitment status, location and first-posted date. EnrollFeed runs that kind of search each week for new studies listed as recruiting with US sites and sends the result as one list grouped by state and lead sponsor, with a link to every record.

Can I use this to find clinical trial site leads?

It lists public study records: which sponsors posted new recruiting studies and which US facilities are listed as recruiting sites. It does not include contact details, and it does not promise meetings, contracts or enrollment. Check each record before any outreach.

Where does the data come from?

ClinicalTrials.gov, a U.S. government database. The sponsor or investigator is responsible for the accuracy of each record. This product is not affiliated with or endorsed by NIH, NLM, or ClinicalTrials.gov.

Do you include investigator or site contact details?

No. We do not include contact names, phone numbers or email addresses from the study records. When an individual investigator is the lead sponsor, we show “Individual investigator” with their institution instead of their name.

Is this medical or enrollment advice?

No. EnrollFeed is a business data list for research staffing firms, site networks and recruitment vendors. It is not medical or enrollment advice. If you are looking for a study to join, search ClinicalTrials.gov and talk with your doctor.

When is it delivered?

Weekly by email, Monday by default.

How much does it cost?

$149 per month for one recipient, or $299 per month for a team. There is no free tier. You can ask for a free one-week sample by emailing hello@enrollfeed.com.

How do billing and cancellation work?

Monthly, renewing automatically. Cancel anytime from the Stripe link in your receipt; cancellation takes effect at the end of the paid period. No refunds for partial months, but we refund your first charge if you ask within 7 days of it. US buyers only.